Kamada Ltd.

Healthcare

NASDAQ:KMDA · NASDAQ Global Select

Market Cap $415.92M Beta 0.15 P/E (TTM) 21.6

$7.44 +0.00%

+$0.00 today

52W Low $6.50High $9.35

Vol 0.03M · Avg 0.06M

EPS (TTM)$0.35

Div Yield3.36%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+11.38%

Period High

$9.04

Period Low

$6.41

Latest

$7.44

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tactile Systems Technology, Inc.

NASDAQ:TCMD

$593.46M

Solid Biosciences Inc.

NASDAQ:SLDB

$556.28M

XOMA Royalty Corp.

NASDAQ:XOMA

$524.09M

Evolus, Inc.

NASDAQ:EOLS

$443.20M

PureTech Health plc

NASDAQ:PRTC

$424.07M

Auna S.A.

NYSE:AUNA

$364.93M

Semler Scientific, Inc.

SMLR

$310.75M

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

$300.28M

Quantum-Si incorporated

NASDAQ:QSI

$187.28M

Galectin Therapeutics Inc.

NASDAQ:GALT

$175.84M

What is the latest KMDA filing?

The latest filing shown is 6-K dated Jun 1, 2026.

How many recent filings does KMDA have?

Intrinsic Alpha currently shows 20 recent filings for KMDA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.